AMANDA CHASE: Open Payments
NPI 1992197776 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,030 in 55 payments from 13 companies in 2025. Trend: 2023 $353 · 2024 $556 · 2025 $1,030
Food & beverage: $1,030
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $260 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $219 |
| Ardelyx, Inc. | 5 | $98 |
| Madrigal Pharmaceuticals | 4 | $83 |
| Celltrion USA Inc. | 3 | $71 |
| Intercept Pharmaceuticals, Inc. | 3 | $61 |
| QOL Medical, LLC | 2 | $52 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| Janssen Biotech, Inc. | 2 | $34 |
Products named: ENTYVIO, RINVOQ, IBSRELA, REZDIFFRA, VEGZELMA, SKYRIZI, OCALIVA, CREON.
Industry payments across NC — which companies pay providers there.
